SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

AGM Statement

10 Sep 2013 07:00

RNS Number : 5749N
Oxford Instruments PLC
10 September 2013
 



Oxford Instruments plc

Chairman's AGM Statement 2013

  

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:

 

"In June 2011 we outlined our 14 Cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It was anticipated that this objective would be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted acquisitions.

 

The year to March 2013 was the second year of the 14 Cubed plan and we saw compound revenue growth of 15.6% over the two years with return on sales last year of 14.2%.

 

In the current year, average monthly orders in our Nanotechnology Tools sector are ahead of last year in Asia but are behind in North America and Europe as government agencies in these territories examine their spending on Research and Development. We believe this is particularly true in the USA where the uncertainty caused by budget sequestration has caused orders to be delayed. Asylum Technology, which we acquired in December 2012, is performing well, with results in line with expectations.

 

Our Industrial Products sector has seen growth in average monthly orders over the previous year in Asia and Europe as global economies begin to recover. North America is still down on the prior year but the trend is improving.

 

Our third party service business is performing well with the recently acquired Platinum Medical Imaging business continuing to gain traction and delivering the integration benefits.

  

Outlook

The growth in the order intake rate in Industrial Products and third party Service is encouraging but the slowness in R&D markets in the Western economies means that the year is likely to be more second half weighted than has been seen in recent periods. This will be aided by the continuing recovery in trading conditions in North America

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Rory King

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUKVKROBAKRAR
Date   Source Headline
6th Jun 20172:14 pmPRNTotal Voting Rights
4th May 20171:56 pmPRNTotal Voting Rights
26th Apr 20177:30 amRNSSale of Industrial Analysis business to HHT
13th Apr 20177:00 amRNSTrading Statement
3rd Apr 20173:25 pmPRNTotal Voting Rights
27th Feb 20179:34 amPRNHolding(s) in Company
2nd Feb 20171:25 pmPRNTotal Voting Rights
31st Jan 20174:31 pmPRNHolding(s) in Company
30th Jan 20174:43 pmPRNHolding(s) in Company
3rd Jan 201711:30 amPRNBlocklisting - Interim Review
18th Nov 20167:00 amRNSDisposal
15th Nov 20167:00 amRNSHalf-year Report
14th Nov 201612:52 pmPRNDirector Declaration
1st Nov 201611:07 amPRNTotal Voting Rights
26th Oct 20167:00 amPRNHolding(s) in Company
14th Sep 201610:17 amPRNResult of AGM
13th Sep 20167:00 amRNSAGM Statement
1st Aug 20164:14 pmPRNTotal Voting Rights
5th Jul 20161:26 pmPRNTotal Voting Rights
5th Jul 20161:19 pmPRNBlocklisting - Interim Review
21st Jun 20162:51 pmPRNDirector/PDMR Shareholding
15th Jun 20167:00 amRNSFinal Results
13th Jun 20161:44 pmPRNDirector/PDMR Shareholding
7th Jun 20163:31 pmRNSDirectorate Change
12th May 20164:26 pmPRNDirector/PDMR Shareholding
9th May 20167:00 amRNSDirectorate Change
18th Apr 20167:00 amPRNDirector/PDMR Shareholding
11th Apr 201610:49 amPRNDirectorate Change
14th Mar 20163:54 pmPRNDirector/PDMR Shareholding
3rd Mar 201611:03 amPRNHolding(s) in Company
24th Feb 20163:47 pmPRNHolding(s) in Company
24th Feb 20167:00 amRNSDirector Declaration & Directorate Change
23rd Feb 201611:52 amPRNNotification of Home State
16th Feb 201611:07 amPRNDirector/PDMR Shareholding
12th Feb 20167:00 amRNSAppointment of Group Finance Director
2nd Feb 20167:00 amRNSAppointment of Non-Executive Director
22nd Jan 20167:00 amRNSTrading Statement
15th Jan 20167:00 amRNSNotice of Trading Update
14th Jan 20161:51 pmPRNDirector/PDMR Shareholding
4th Jan 201612:07 pmPRNBlocklisting - Interim Review
1st Dec 201510:37 amPRNHolding(s) in Company
26th Nov 20153:41 pmPRNHolding(s) in Company
24th Nov 20157:00 amRNSDisposal
12th Nov 20152:23 pmPRNDirector/PDMR Shareholding
10th Nov 20153:23 pmPRNHolding(s) in Company
10th Nov 20157:01 amRNSDirectorate Changes
10th Nov 20157:00 amRNSHalf Yearly Report
27th Oct 201510:06 amRNSReplacement re: Directorate Change
27th Oct 20157:00 amRNSDirectorate Change
14th Oct 201511:09 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.